These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T. Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539 [Abstract] [Full Text] [Related]
4. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S, Itabe H, Takano T. Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526 [Abstract] [Full Text] [Related]
5. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Sakata N, Uesugi N, Takebayashi S, Nagai R, Jono T, Horiuchi S, Takeya M, Itabe H, Takano T, Myint T, Taniguchi N. Cardiovasc Res; 2001 Feb 01; 49(2):466-75. PubMed ID: 11164857 [Abstract] [Full Text] [Related]
11. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S. Atherosclerosis; 1999 Jan 01; 142(1):67-77. PubMed ID: 9920507 [Abstract] [Full Text] [Related]
15. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. Miyata T, Inagi R, Asahi K, Yamada Y, Horie K, Sakai H, Uchida K, Kurokawa K. FEBS Lett; 1998 Oct 16; 437(1-2):24-8. PubMed ID: 9804165 [Abstract] [Full Text] [Related]
16. Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Uesugi N, Sakata N, Nangaku M, Abe M, Horiuchi S, Hisano S, Iwasaki H. Am J Kidney Dis; 2004 Aug 16; 44(2):224-38. PubMed ID: 15264180 [Abstract] [Full Text] [Related]
17. Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Drinda S, Franke S, Canet CC, Petrow P, Bräuer R, Hüttich C, Stein G, Hein G. Ann Rheum Dis; 2002 Jun 16; 61(6):488-92. PubMed ID: 12006318 [Abstract] [Full Text] [Related]
20. Increased level of glycoxidation product N(epsilon)-(carboxymethyl)lysine in rat serum and urine proteins with aging: link with glycoxidative damage accumulation in kidney. Hamelin M, Borot-Laloi C, Friguet B, Bakala H. Arch Biochem Biophys; 2003 Mar 15; 411(2):215-22. PubMed ID: 12623070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]